Identification of a Recurrence Signature and Validation of Cell Infiltration Level of Thyroid Cancer Microenvironment
Though many patients with thyroid cancer may be indolent, there are still about 50% lymph node metastases and 20% the recurrence rates. There is still no ideal method to predict its relapse. In this study, we analyzed the gene transcriptome profiles of eight Gene Expression Omnibus (GEO), and next s...
Main Authors: | Liang Zhang, Ying Wang, Xiaobo Li, Yang Wang, Kaile Wu, Jing Wu, Yehai Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2020.00467/full |
Similar Items
-
Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer
by: Cheng Yang, et al.
Published: (2022-12-01) -
Identifying hub genes of papillary thyroid carcinoma in the TCGA and GEO database using bioinformatics analysis
by: Ying Wan, et al.
Published: (2020-07-01) -
Identification of a Novel Cuproptosis-Related Gene Signature and Integrative Analyses in Thyroid Cancer
by: Jiapeng Huang, et al.
Published: (2023-03-01) -
Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer
by: Facai Zhang, et al.
Published: (2021-05-01) -
Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer
by: Jingchao Liu, et al.
Published: (2021-05-01)